Protagonist Therapeutics PTGX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's change in AP?
- Protagonist Therapeutics (PTGX) reported change in AP of $3M in Q1 2026.
- How has Protagonist Therapeutics's change in AP changed year-over-year?
- Protagonist Therapeutics's change in AP increased by 142.8% year-over-year, from $1.24M to $3M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.